FDA Moves Generic Dapagliflozin a Step Closer to US Sales FDA Moves Generic Dapagliflozin a Step Closer to US Sales

The FDA added two different dose formulations of generic dapagliflozin to its Orange Book of therapeutic equivalents, but a patent barrier remains in place.FDA Approvals
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Diabetes & Endocrinology News Alert Source Type: news